Ann: Quarterly Activities and Cash Flow Reports - 31 Mar 2023, page-9

First 9 Last

Share
Profile

Follow
Farmerfreddo

266 Posts.

54

29/04/23

06:25

Post #: 67519783
Share

Originally posted by Pseudo19: ↑

There are lots of variables and plenty the public doesn't know.
The latest sales price was US$673/T. Realistically this could fall another 10% within a few months.
The exchange rate is probably as good as they can expect looking at the long term chart.
The last operating cost estimates (in 2021) were for the 120Ktpa operation: $375/T plus royalties. Royalties are 2.5% WA (discounted 50% until 2027 IF sale price is below A$1000/T), NT royalty 0.75% and Smoothy/founders royalty 1.9%. So Another $45/T.
The operating costs for 60Ktpa (assuming they achieve this) will be higher. $450/T?
If the price drops back to A$900/T with costs of $450/T, the margin from 60KTpa is $27M.
We know the credit was good but interest rates have risen significantly since the loans were written. NAIF talks about fixed rates and the Government cost of borrowing. Presumably the rates have risen.
The loan is $195M. At 4% the interest is $7.8M.

Based on all the assumptions above, 1500T per month may be enough to cover the monthly interest. This is absolute survival mode with no capacity to repay accrued interest, deal with any further issues requiring capital and zero ability to fund any expansion.

If the Aussie dollar rises to 69 cents and SOP price drops to US$600/T, both very possible, the margin is $25M.

All of the above is assuming the current plant upgrades actually work.

With 2B shares on issue it's hard to get excited about a possible share price at 60Ktpa or 120Ktpa.

Expand

Given what has transpired, I would be happy with $25 m margin for 60tpa. It would be best outcome to start before operation goes to120

Last edited by Farmerfreddo: 29/04/23

KLL Price at posting: 3.4¢ Sentiment: Hold Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

OCC

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

MSB

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

SRL

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

SPR

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

PL3

Patagonia looks to raise $2.15M for South American exploration and development

There are more pages in this discussion • 45 more messages in this thread...

First 9 Last

Add KLL (ASX) to my watchlist

(20min delay)
Last $7.28		Change 0.000(0.00%)		Mkt cap ! $174.4K

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Ann: Quarterly Activities and Cash Flow Reports - 31 Mar 2023, page-9

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Patagonia looks to raise $2.15M for South American exploration and development

Featured News

Featured News

Ann: Quarterly Activities and Cash Flow Reports - 31 Mar 2023, page-9

Top Stories

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Patagonia looks to raise $2.15M for South American exploration and development

Featured News

Featured News